12 January 2018 by CBRNe World Staff 0
908 Devices, a pioneer of analytical devices for chemical and biomolecule analysis, today announced a new software update for MX908™, which includes the introduction of a new mission mode – Drug Hunter.
11 January 2018 by CBRNe World Staff 0
Mystaire® Inc, Creedmoor NC announces the release of the Latitude™ Fentanyl Filtered Hood, which provides law enforcement professionals with another safety tool when handling fentanyl and its analogues. Latitude maximizes user accessibility and incorporates redundant filtration for added safety and easy maintenance. The Latitude fentanyl filtered hood was designed with rear wall pre-filter and HEPA filtration. This design pulls potentially harmful particulate away from the operator’s breathing zone in an even horizontal airflow path, increasing particulate capture.
Battelle has been awarded a contract by the Intelligence Advanced Research Projects Activity (IARPA) to develop threat assessment software to help prevent the creation of dangerous organisms.
IARPA’s Functional Genomic and Computational Assessment of Threats (Fun GCAT) program is aimed at the creation of a critical new capability to counter potential threats associated with advancements in biotechnology.
09 January 2018 by CBRNe World Staff 0
First Line Technology, a leading provider of disaster preparedness and emergency response equipment, announced it has been awarded a 10-year fielded contract through the United States Department of Defense’s (DOD) Joint Enterprise-Research, Development, Acquisition, and Production/Procurement (JE-RDAP) omnibus Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle.
The Federal Emergency Management Agency’s Center for Domestic Preparedness (CDP) announced today that the Center will resume using nerve agents and biologicals in some of its hazardous materials training courses on Jan. 11.
05 January 2018 by CBRNe World Staff 0
On January 16th 2018 at 1:00 p.m. (ET) the CDC will be holding a Grand Rounds webcast to disseminate information on what public health programs have done on a federal, state, and local level to prepare for a nuclear detonation. there will also be an opportunity to learn how planning and preparation efforts for a nuclear detonation are similar and different from other emergency response planning efforts.
Block MEMS, has been selected to participate in an $8,276,161,000 contract for Joint Enterprise Research, Development, Acquisition, Production and Procurement (JE-RDAP) program to support research, development and sale of chemical, biological, radiological, nuclear (CBRN), and high-yield explosives defense systems, capabilities, equipment, supplies and material.
The JE-RDAP is an enterprise-wide omnibus Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle awarded by the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) and will be used to execute activities related to their mission to protect the nation against Weapons of Mass Destruction.
Block’s products are based on the use of Mid-Infrared Spectroscopy for detection of Chemical Threats and fit well within the scope of the JE-RDAP.
2018 will be fast upon us so we wanted to give you a heads up about our next CBRNe Convergence, November 6th - 8th 2018, so that you can save the date now.
Next year will see us head to Orlando and the Rozen Plaza Hotel for another great event filled with insightful lectures, demonstrations and exhibits.
Full details available at www.cbrneworld.com/southamerica2018
Comisario General Juan Benitez, Superintendente,Argentine Fire Service
David Smith, Nuclear Security Coordinator,IAEA
LTC Jorge Frias Barrera, CBRN Company Commander,Argentine Army
Dr Caitriona McLeish, co-director of the Harvard Sussex Program, Sussex University
Lt. Col.Vasconcelos, Commander 1st CBRN Defense Battalion Brazilian Army
Capt. Jose Maria Martin Corrochano, Jefe Interino Plana Mayor del Grupo de Intervención en EmergenciasTecnológicas y Medioambientales, GIETMA
Augusto Garcia, BombTechnician, National Police, Peru
20 December 2017 by CBRNe World Staff 0
Scientists and engineers at the Lawrence Livermore National Laboratory (LLNL) have developed what they are calling a “brain-on-a-chip” device aimed at testing and predicting the effects of biological and chemical agents, disease, or pharmaceutical drugs on the brain over time without the need for human or animal subjects.
The device, part of the Lab’s iCHIP (in-vitro Chip-Based Human Investigational Platform) project, simulates the central nervous system by recording neural activity from multiple brain cell types deposited and grown onto microelectrode arrays. The platform, described in the journal PLOS One, could help scientists understand how brain cells connect and interact, combat brain disorders, determine how soldiers are affected by exposure to chemical and biological weapons and develop antidotes to counteract those effects.